| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |